Treatment of Anxiety Disorders with Tricyclic Antidepressants

Anxiety Disorders

Volumn , Issue , 2007, Pages 363-380

  Rosenberg, R ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anxiety disorders; Clomipramine; Obsessive compulsive disorder; Tolerability; Tricyclic antidepressants

Indexed keywords

EID: 84952066407     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470986844.ch19     Document Type: Chapter

References (100)

1. Abramowitz, J.S. (1997) Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review. J Consult Clin Psychol 65(1), 44-52.
2. Allgulander, C. (1999) Paroxetine in social anxiety disorder: a randomized placebo-controlled study. Acta Psychiatr Scand 100(3), 193-8.
3. American Psychiatric Association (1980) Diagnostic Statistical Manual of Mental Disorders, 3rd edn. American Psychiatric Association, Washington, D.C.
4. American Psychiatric Association (1994) Diagnostic Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, D.C.
5. Andersch, S., Ottosson, J.-O., Bech, P. et al. (1991) Efficacy and safety of alprazolam, imipramine, and placebo in the treatment of panic disorder. Acta Psychiatr Scand 83 (Suppl. 365), 18-27.
6. Anderson, I.M. & Tomenson, B.M. (1995) Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ 310, 1433-8.
7. Balestrieri, M., Ruggeri, M. & Bellantuono, C. (1989) Drug treatment of panic disorder-a critical review of controlled clinical trials. Psychiatr Dev 4, 337-50.
8. Ballenger, J.C. (1999) Current treatments of the anxiety disorders in adults. Biol Psychiatry 46(11), 1579-94.
9. Ballenger, J.C., Davidson, J.R., Lecrubier, Y. et al. (1998) Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 59 (Suppl. 17), 54-60.
10. Ballenger, J.C., Davidson, J.R., Lecrubier, Y. et al. (2000) Consensus statement on post-traumatic stress disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 61 (Suppl. 5), 60-6.
11. Barlow, D.H., Gorman, J.M., Shear, M.K. & Woods, S.W. (2000) Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 283(19), 2529-36.
12. Barlow, D.H. & Wincze, J. (1998) DSM-IV and beyond: what is generalized anxiety disorder? Acta Psychiatr Scand Suppl 393, 23-9.
13. Bisserbe, J.C., Lane, R.M., Flament, M.F. & Franco-Belgian OCD Study Group (1997) A double-blind comparison of sertraline and clompramine in outpatients with obsessive-compulsive disorder. Eur Psychiatry 12, 82-93.
14. Boyer, W. (1995) Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 10(1), 45-9.
15. Brown, T.A. (1997) The nature of generalized anxiety disorder and pathological worry: current evidence and conceptual models. Can J Psychiatry 42, 817-25.
16. Burrows, G.D., Judd, F.K. & Norman, T.R. (1993) Long-term drug treatment of panic disorder. J Psychiatr Res 27 (Suppl. 1), 111-25.
17. Caillard, V., Rouillon, F., Viel, J.F. & Markabi, S. (1999) Comparative effects of low and high doses of clomipramine and placebo in panic disorder: a double-blind controlled study. Acta Psychiatr Scand 99(1), 51-8.
18. Charney, D.S., Deutch, A.Y., Krystal, J.H., Southwick, S.M. & Davis, M. (1993) Psychobiologic mechanisms of post-traumatic stress disorder. Arch Gen Psychiatry 50, 295-305.
19. Clark, D.M., Salkovskis, P.M., Hackmann, A., Middleton, H., Anastasiades, P. & Gelder, M. (1994) A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Br J Psychiatry 164, 759-69.
20. Clomipramine Collaborative Study Group (The) (1991) Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group [see comments]. Arch Gen Psychiatry 48, 730-8.
21. Coplan, J.D. & Lydiard, R.B. (1998) Brain circuits in panic disorder. Biol Psychiatry 44, 1264-76.
22. Cross-National Collaborative Panic Study (CNCPS) (1992) Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Br J Psychiatry 160, 191-202.
23. Davidson, J.R., Kudler, H.S., Saunders, W.B. et al. (1993) Predicting response to amitriptyline in post-traumatic stress disorder. Am J Psychiatry 150(7), 1024-9.
24. Davidson, J., Kudler, H., Smith, R. et al. (1990) Treatment of post-traumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry 47, 259-66.
25. Davidson, J.R., Malik, M.L. & Sutherland, S.N. (1997) Response characteristics to antidepressants and placebo in post-traumatic stress disorder. Int Clin Psychopharmacol 12(6), 291-6.
26. Deltito, J.A., Argyle, N. & Klerman, G.L. (1991) Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment. J Clin Psychiatry 52, 121-7.
27. Den Boer, J.A. & Westenberg, H.G. (1988) Effect of a sero-tonin and noradrenaline uptake inhibitor in panic disorder: a double-blind comparative study with fluvoxamine and maprotiline. Int Clin Psychopharmacol 3(1), 59-74.
28. Donoghue, J. (2000) Antidepressant use patterns in clinical practices: comparisons among tricyclic antidepressants and selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 403, 57-61.
29. Fahy, T.J., O'Rourke, D., Brophy, J., Schazmann, W., Sciascia, S. (1992) The Galway Study of Panic Disorder. I. Clomipramine and lofepramine in DSM-III-R panic disorder: a placebo-controlled trial. Journal of Affect Disord 25, 63-75.
30. Fallon, B.A., Liebowitz, M.R., Campeas, R. et al. (1998) Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study. Arch Gen Psychiatry 55(10), 918-24.
31. Frank, J.B., Kosten, T.R., Giller, E.L. & Dan, E. (1988) A randomized clinical trial of phenelzine and imipramine for post-traumatic stress disorder. Am J Psychiatry 145, 1289-91.
32. Freeman, C.P., Trimble, M.R., Deakin, J.F., Stokes, T.M. & Ashford, J.J. (1994) Fluvoxamine versus clomipramine in the treatment of obsessive-compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. J Clin Psychiatry 55(7), 301-5.
33. Gentil, V., Lotufo-Neto, F., Andrade, L. et al. (1993) Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with imipramine. J Psychopharmacol 7, 316-24.
34. Gloger, S., Grunhaus, L., Gladic, D., O'Ryan, F., Cohen, L. & Codner, S. (1989) Panic attacks and agoraphobia: lowdose clomipramine treatment. J Clin Psychopharmacol 9(1), 28-32.
35. Goddard, A.W. & Charney, D.S. (1997) Toward an inte-grated neurobiology of panic disorder. J Clin Psychiatry 58 (Suppl. 2), 4-11.
36. Gould, R.A., Otto, M.W. & Pollack, M.H. (1995) A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev 15, 819-44.
37. Greist, J.H., Jefferson, J.W., Kobak, K.A., Katzelnick, D.J. & Serlin, R.C. (1995) Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis. Arch Gen Psychiatry 52(1), 53-60.
38. Hoehn-Saric, R., McLeod, D.R. & Zimmerli, W.D. (1988) Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms. J Clin Psychiatry 49(8), 293-301.
39. Hoehn-Saric, R., Ninan, P., Black, D.W. et al. (2000) Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders. Arch Gen Psychiatry 57(1), 76-82.
40. Johnstone, E.C., Owens, D.G., Frith, C.D. et al. (1980) Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychol Med 10(2), 321-8.
41. Judd, L.L., Kessler, R.C., Paulus, M.P., Zeller, P.V., Wittchen, H.U. & Kunovac, J.L. (1998) Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS). Acta Psychiatr Scand Suppl 393, 6-11.
42. Kahn, R.J., McNair, D.M., Lipman, R.S. et al. (1986) Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients. Arch Gen Psychiatry 43(1), 79-85.
43. Kalus, O., Asnis, G.M., Rubinson, E. et al. (1991) Desipramine treatment in panic disorder. J Affect Disord 21, 239-44.
44. Katschnig, H., Amering, M., Stolk, J.M. et al. (1995) Longterm follow-up after a drug trial for panic disorder. Br J Psychiatry 167(4), 487-94.
45. Katz, R.J., DeVeaugh-Geiss, J. & Landau, P. (1990) Clomipramine in obsessive-compulsive disorder. Biol Psychiatry 28(5), 401-14.
46. Kessler, R.C. (2000) Post-traumatic stress disorder: the burden to the individual and to society. J Clin Psychiatry 61 (Suppl. 5), 4-12.
47. Klein, D.F. (1964) Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 5, 397-408.
48. Klein, D.F. (1981) Anxiety reconceptualized. In: Anxiety: New Research and Changing Concepts (D.F. Klein & J. Rabkin (eds), pp. 235-63). Raven Press, New York.
49. Klein, D.F. (2000) Flawed meta-analyses comparing psychotherapy with pharmacotherapy. Am J Psychiatry 157(8), 1204-11.
50. Klerman, G.L. (1988) Overview of the Cross-National Collaborative Panic Study. Arch Gen Psychiatry 45, 407-12.
51. Klerman, G.L., Hirschfeld, R.M.A., Weissman, M.M. et al. (eds) (1993) Panic Anxiety and its Treatments. American Psychiatric Press, Washington, D.C.
52. Kobak, K.A., Greist, J.H., Jefferson, J.W., Katzelnick, D.J. & Henk, H.J. (1998) Behavioral versus pharmacological treatments of obsessive-compulsive disorder: a meta-analysis. Psychopharmacology 136(3), 205-16.
53. Koran, L.M., McElroy, S.L., Davidson, J.R., Rasmussen, S.A., Hollander, E. & Jenike, M.A. (1996) Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. J Clin Psychopharmacol 16(2), 121-9.
54. Koran, L.M., Pallanti, S., Paiva, R.S. & Quercioli, L. (1998) Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder. Eur Neuropsychopharmacol 8(2), 121-6.
55. Kosten, T.R., Frank, J.B., Dan, E., McDougle, C.J. & Giller, E.L.J. (1991) Pharmacotherapy for post-traumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis 179, 366-70.
56. Lecrubier, Y., Bakker, A., Dunbar, G. & Judge, R. (1997) A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta Psychiatr Scand 95(2), 145-52.
57. Lecrubier, Y. & Judge, R. (1997) Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta Psychiatr Scand 95(2), 153-60.
58. Lepola, U.M., Wade, A.G., Leinonen, E.V. et al. (1998) A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder. J Clin Psychiatry 59(10), 528-34.
59. Liebowitz, M.R., Fyer, A.J., Gorman, J.M. et al. (1988) Tricyclic therapy of the DSM-III anxiety disorders: a review with implications for further research. J Psychiatr Res 22 (Suppl. 1), 7-32.
60. Lopez-Ibor, J.J., Jr, Saiz, J., Cottraux, J. et al. (1996) Doubleblind comparison of fluoxetine versus clomipramine in the treatment of obsessive-compulsive disorder. Eur Neuropsychopharmacol 6(2), 111-18.
61. Lotufo-Neto, F., Bernik, M., Ramos, R.T. et al. (2001) A dose-finding and discontinuation study of clomipramine in panic disorder. J Psychopharmacol 15(1), 13-17.
62. Maier, W., Rosenberg, R., Argyle, N. et al. (1991a) Subtyping panic disorder by major depression and avoidance behavior and the response to active treatment. Eur Arch Psychiatry Clin Neurosci 241, 22-30.
63. Maier, W., Roth, S.M., Argyle, N. et al. (1991b) Avoidance behavior: a predictor of the efficacy of pharmacotherapy in panic disorder? Eur Arch Psychiatry Clin Neurosci 241, 151-8.
64. Marcourakis, T., Gorenstein, C., Ramos, R.T. & Da Motto, S.J. (1999) Serum levels of clomipramine and desmethyl-clomipramine and clinical improvement in panic disorder. J Psychopharmacol 13(1), 40-4.
65. Matuzas, W. & Jack, E. (1991) The drug treatment of panic disorder. Psychiatr Med 9, 215-43.
66. Mavissakalian, M.R., Jones, B., Olson, S. & Perel, J.M. (1990) Clomipramine in obsessive-compulsive disorder: clinical response and plasma levels. J Clin Psychopharmacol 10(4), 261-8.
67. Mavissakalian, M.R. & Perel, J.M. (1995) Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships. Am J Psychiatry 152(5), 673-82.
68. Mavissakalian, M.R. & Perel, J.M. (1996) The relationship of plasma imipramine and N-desmethylimipramine to response in panic disorder. Psychopharmacol Bull 32(1), 143-7.
69. Mavissakalian, M.R. & Perel, J.M. (1999) Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. Arch Gen Psychiatry 56(9), 821-7.
70. Meyer, U.A., Amrein, R., Balant, L.P. et al. (1996) Antidepressants and drug-metabolizing enzymes-Expert Group Report. Acta Psychiatr Scand 93(2), 71-9.
71. Modigh, K. (1989) Antidepressant drugs in anxiety disorders. Acta Psychiatr Scand 76 (Suppl. 335), 57-71.
72. Modigh, K., Westberg, P. & Eriksson, E. (1992) Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial. J Clin Psychopharmacol 12, 251-61.
73. Montgomery, S.A. (1998) SSRIs in obsessive-compulsive disorder. In: SSRIs in Depression and Anxiety (S.A. Montgomery & J.A. Den Boer (eds), pp. 149-72). John Wiley & Sons, Chichester.
74. Munjack, D.J., Usigli, R., Zulueta, A. et al. (1988) Nortriptyline in the treatment of panic disorder and agoraphobia with panic attacks. J Clin Psychopharmacol 8, 204-7.
75. Nair, N.P., Bakish, D., Saxena, B., Amin, M., Schwartz, G. & West, T.E. (1996) Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder. Anxiety 2(4), 192-8.
76. Nutt, D.J. (2000) The psychobiology of post-traumatic stress disorder. J Clin Psychiatry 61 (Suppl. 5), 24-9.
77. Pélissolo, A. & Lépine, J.-P. (1998) Epidemiology of depression and anxiety disorders. In: SSRIs in Depression and Anxiety (S.A. Montgomery & J.A. Den Boer (eds), pp. 1-21). John Wiley & Sons, Chichester.
78. Piccinelli, M., Pini, S., Bellantuono, C. & Wilkinson, G. (1995) Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. Br J Psychiatry 166(4), 424-43.
79. Rickels, K., Downing, R., Schweizer, E. & Hassman, H. (1993) Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry 50(11), 884-95.
80. Rocca, P., Fonzo, V., Scotta, M., Zanalda, E. & Ravizza, L. (1997) Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr Scand 95(5), 444-50.
81. Rosenberg, R. (1999) Treatment of panic disorder with tricyclics and MAOIs. In: Panic Disorder: Clinical Diagnosis, Management and Mechanisms (D. Nutt, J.C. Ballenger & J.-P. Lépine (eds), pp. 125-44). Martin Dunitz Ltd, London.
82. Rosenberg, R. & Jensen, P.N. (1994) Treatment of panic disorder with alprazolam and imipramine: clinical relevance of DSM-III dysthymia. Eur Psychiatry 9, 27-32.
83. Rosenberg, R., Ottosson, J.O., Bech, P., Mellergard, M. & Rosenberg, N.K. (1991) Validation criteria for panic disorder as a nosological entity. Acta Psychiatr Scand 83 (Suppl. 365), 7-17.
84. Roy-Byrne, P.P. & Cowley, D.S. (1994) Course and outcome in panic disorder: a review of recent follow-up studies. Anxiety 1(4), 151-60.
85. Sallee, F.R., Koran, L.M., Pallanti, S., Carson, S.W. & Sethuraman, G. (1998) Intravenous clomipramine challenge in obsessive-compulsive disorder: predicting response to oral therapy at 8 weeks. Biol Psychiatry 44(3), 220-27.
86. Sanchez, C. & Hyttel, J. (1999) Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Molecular Neurobiology 19(4), 467-89.
87. Sasson, Y., Iancu, I., Fux, M., Taub, M., Dannon, P.N. & Zohar, J. (1999) A double-blind cross-over comparison of clomipramine and desipramine in the treatment of panic disorder. Eur Neuropsychopharmacol 9(3), 191-6.
88. Shear, M.K. & Maser, J.D. (1994) Standardized assessment for panic disorder research. A conference report. Arch Gen Psychiatry 51(5), 346-54.
89. Stein, M.B., Liebowitz, M.R., Lydiard, R.B., Pitts, C.D., Bushnell, W. & Gergel, I. (1998) Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial. JAMA 280(8), 708-13.
90. Stein, D.J., Spadaccini, E. & Hollander, E. (1995) Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. Int Clin Psychopharmacol 10(1), 11-18.
91. Taylor, C.B., Hayward, C., King, R. et al. (1990) Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial. J Clin Psychopharmacol 10, 112-18.
92. Thoren, P., Asberg, M., Cronholm, B., Jornestedt, L. & Traskman, L. (1980) Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Arch Gen Psychiatry 37(11), 1281-5.
93. van Balkom, A.J., Bakker, A., Spinhoven, P., Blaauw, B.M., Smeenk, S. & Ruesink, B. (1997) A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments. J Nerv Ment Dis 185(8), 510-16.
94. van Balkom, A.J., De Haan, E., van Oppen, P., Spinhoven, P., Hoogduin, K.A. & Van Dyck, R. (1998) Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive-compulsive disorder. J Nerv Ment Dis 186(8), 492-9.
95. Versiani, M. (2000) A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia). World J Biol Psychiatry 1, 27-33.
96. Vestergaard, P., Gram, L.F., Kragh-Sorensen, P., Bech, P., Reisby, N. & Bolwig, T.G. (1993) Therapeutic potentials of recently introduced antidepressants. Danish University Antidepressant Group Psychopharmacological Series 10, 190-8.
97. Wade, A.G., Lepola, U., Koponen, H.J., Pedersen, V. & Pedersen, T. (1997) The effect of citalopram in panic disorder. Br J Psychiatry 170, 549-53.
98. Wilkinson, G., Balestrieri, M., Ruggeri, M. & Bellantuono, C. (1991) Meta-analysis of double-blind placebo-controlled trials of antidepressants and benzodiazepines for patients with panic disorders. Psychol Med 21, 991-8.
99. Zohar, J. & Judge, R. (1996) Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators. Br J Psychiatry 169(4), 468-74.
100. Zohar, J. & Westenberg, H.G. (2000) Anxiety disorders: a review of tricyclic antidepressants and selective serotonin re-uptake inhibitors. Acta Psychiatr Scand Suppl 403, 39-49.